Brad Cann is the founder of Resverlogix. Resverlogix has raised $500M in total funding. Based in Calgary, Alberta, Canada.
Brad Cann is the Chief Financial Officer at Resverlogix, a biopharmaceutical company focused on developing therapeutics for cardiovascular diseases and Alzheimer's disease. He joined Resverlogix in 2009. Cann has more than 25 years of experience, with over 20 years in senior management roles.
Full founder directory · Investor directory · Company funding database · Fundraising library